Castle Biosciences (CSTL) Inventory (2018 - 2026)

Castle Biosciences has disclosed Inventory across 9 years of filings, most recently posting $10.5 million for Q1 2026.

• Inventory for Q1 2026 came in at $10.5 million, up 52.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 52.74% YoY), and the FY2025 annual result was $10.3 million, up 26.05% from the prior year.
• Inventory came in at $10.5 million for Q1 2026 at Castle Biosciences, up from $10.3 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $10.5 million in Q1 2026 to a low of $2.4 million in Q1 2022.
• The 5-year median for Inventory is $6.8 million (2025), against an average of $6.6 million.
• Across the five-year window, Inventory surged 99.55% in 2023 and slipped 10.41% in 2025, its largest moves.
• Castle Biosciences' Inventory stood at $4.0 million in 2022, then soared by 99.55% to $7.9 million in 2023, then increased by 2.43% to $8.1 million in 2024, then gained by 26.05% to $10.3 million in 2025, then rose by 2.02% to $10.5 million in 2026.
• The last three Inventory figures came in at $10.5 million (Q1 2026), $10.3 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.